The vector of anti-MAGEA4 T cell receptor (TCR) is constructed for the engineering of T cell to target Human MAGEA4. The T cells are genetically modified through transduction with a retroviral vector expressing MAGEA4-specific T cell receptor. And the vector product was designed for the treatment of Esophageal cancer, a head and neck cancer, a non-small cell pulmonary cancer, a stomach cancer and Hodgkin's disease.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|CAR-WFY5085||Anti-MAGEA4 (CBFYM-1312) h(CD28-CD3ζ) CAR, pCDCAR1|
|VP-TCR-C257||Lenti-MAGE-A4 T cell receptor (2-28) Viral Particle|
|CAR-CQ4995||Anti-MAGEA4 (8BA20) h(CD28-CD3ζ) CAR, pCDCAR1|
|CAR-CQ4994||Anti-MAGEA4 (8BA19) h(CD28-CD3ζ) CAR, pCDCAR1|
|CAR-WFY5084||Anti-MAGEA4 (CBFYM-1311) h(CD28-CD3ζ) CAR, pCDCAR1|
|CAR-WFY1832||Anti-MAGEA4 (CBFYM-1312) h(41BB-CD3ζ) CAR, pCDCAR1|
|TCR-L063||Human anti-MAGEA4 (NYKRCFPVI) T Cell Receptor, pMX-IRES-GFP|
|DMAb-1832-FY||Mouse Anti-MAGEA4 DNA-encoded mAb (CBFYM-1312), pVAX1|
|CAR-CQ1570||Anti-MAGEA4 (8BA19) h(41BB-CD3ζ) CAR, pCDCAR1|
|DMAb-1831-FY||Mouse Anti-MAGEA4 DNA-encoded mAb (CBFYM-1311), pVAX1|
Copyright © 2007 - 2019 Creative Biolabs. All Rights Reserved